Combination chemotherapy for ovarian cancer--lessons not yet learned?

Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy.

ESMO open·2017

Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma.

Molecular cancer therapeutics·2017

Chemotherapy for Patients with BRCA1 and BRCA2-Mutated Ovarian Cancer: Same or Different?

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2015

Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials.

Clinical cancer research : an official journal of the American Association for Cancer Research·2015

Advanced epithelial ovarian cancer: from standard chemotherapy to promising molecular pathway targets--where are we now?

Anticancer research·2014

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.

Cancer immunology research·2014

Percutaneous Management of Desmoid Tumors.

Current oncology reports·2026

Cardiac Monitoring for Patients Undergoing Treatment With MEK Inhibitor Monotherapy.

Current oncology reports·2026

The Role of Omega-3 Polyunsaturated Fatty Acids in Modulating Inflammation and Breast Cancer: A Systematic Review of In Vitro, Animal, and Human Studies.

Current oncology reports·2026

Periodontitis as a Modulator of Malignant Transformation in Oral Potentially Malignant Disorders: A Narrative Review of Biological Mechanisms and Clinical Implications.

Current oncology reports·2026

Early-Onset Colorectal Cancer: From Epidemiologic Shift to Life-Course Carcinogenesis and Age-Attuned Care.

Current oncology reports·2026

Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma: from Tumor Biology to Biomarker-Guided Strategies.

Current oncology reports·2026

EMB-01, an Anti-EGFR/c-MET Bispecific Antibody, in Patients with Heavily Pretreated Metastatic Colorectal Cancer From a Phase Ib/II, Open-Label, Multicenter Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

First-Line Nivolumab Plus Ipilimumab in Inoperable Epithelioid Malignant Pleural Mesothelioma: Real-World Experience From an Indian Tertiary Care Center.

Cureus·2026

Boswellic Acid and Its Derivatives For the Treatment of Colon Cancer: A Review.

Mini reviews in medicinal chemistry·2026

Phytochemical-Chemotherapeutic Interactions in Gastrointestinal Cancers: Synergistic Mechanisms, Pharmacokinetic Barriers, and Translational Challenges.

Current medicinal chemistry·2026

Ginseng-Containing Sijunzi Decoction Inhibits Colorectal Cancer Progression by Regulating MARCHF3-ALOX15-Mediated Ferroptosis.

The American journal of Chinese medicine·2026

Impact of chemotherapy received prior to testicular tissue cryopreservation on somatic cells from prepubertal to postpubertal males.

Human reproduction (Oxford, England)·2026

Related Experiment Videos

Combination chemotherapy for ovarian cancer--lessons not yet learned?

Related Concept Videos

Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy.

Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma.

Chemotherapy for Patients with BRCA1 and BRCA2-Mutated Ovarian Cancer: Same or Different?

Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials.

Advanced epithelial ovarian cancer: from standard chemotherapy to promising molecular pathway targets--where are we now?

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.

Percutaneous Management of Desmoid Tumors.

Cardiac Monitoring for Patients Undergoing Treatment With MEK Inhibitor Monotherapy.

The Role of Omega-3 Polyunsaturated Fatty Acids in Modulating Inflammation and Breast Cancer: A Systematic Review of In Vitro, Animal, and Human Studies.

Periodontitis as a Modulator of Malignant Transformation in Oral Potentially Malignant Disorders: A Narrative Review of Biological Mechanisms and Clinical Implications.

Early-Onset Colorectal Cancer: From Epidemiologic Shift to Life-Course Carcinogenesis and Age-Attuned Care.

Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma: from Tumor Biology to Biomarker-Guided Strategies.

EMB-01, an Anti-EGFR/c-MET Bispecific Antibody, in Patients with Heavily Pretreated Metastatic Colorectal Cancer From a Phase Ib/II, Open-Label, Multicenter Study.

First-Line Nivolumab Plus Ipilimumab in Inoperable Epithelioid Malignant Pleural Mesothelioma: Real-World Experience From an Indian Tertiary Care Center.

Boswellic Acid and Its Derivatives For the Treatment of Colon Cancer: A Review.

Phytochemical-Chemotherapeutic Interactions in Gastrointestinal Cancers: Synergistic Mechanisms, Pharmacokinetic Barriers, and Translational Challenges.

Ginseng-Containing Sijunzi Decoction Inhibits Colorectal Cancer Progression by Regulating MARCHF3-ALOX15-Mediated Ferroptosis.

Impact of chemotherapy received prior to testicular tissue cryopreservation on somatic cells from prepubertal to postpubertal males.

Related Experiment Videos

Combination chemotherapy for ovarian cancer--lessons not yet learned?

Related Concept Videos

Related Articles